Oversonic Robotics Srl believes that its humanoid robot Robee could transform health care in Europe as it helps address the ...

The U.K. Medicines and Healthcare products Agency (MHRA) has committed to major reforms of how it regulates drugs for rare ...

Uniqure NV is regrouping after a surprise switcheroo by the havoc-beset U.S. FDA regarding phase I/II studies with AMT-130 vs ...

George Tidmarsh, a biopharma industry veteran who’s helmed CDER for a little more than three months, resigned yesterday after being placed on administrative leave two days earlier amid a Health and ...

Manifold Biotechnologies Inc. has signed a strategic research collaboration and license agreement with F. Hoffmann-La Roche ...

Innovent Biologics Co. Ltd. presented data for IBI-3034, a chimeric Fc fusion protein comprising transmembrane activator and ...

The U.S. FDA once again has a leadership gap at the top of its drug center, which already has been ravaged this year by massive terminations, resignations and retirements of senior leaders. George ...

The U.S. CMS has adopted an aggressive payment policy for skin substitutes in the Medicare physician fee schedule for 2026, ...

The Office of Inspector General (OIG) said in a new report that the U.S. Medicare program had overpaid a group of providers ...

ADAM9 (a disintegrin and metalloproteinase 9) is overexpressed in several gastrointestinal cancers, with expression levels ...

Biopharma partnerships involving nonprofits have declined sharply since peaking during the pandemic. Deal value surged from ...

Alterations in HER2 are known oncogenic drivers in several solid tumors, including breast, lung and gastric cancers, among ...